Zeev's Turnips Patch-No Politics (ZEEV)

[late bloomer]

EPCT up 26% pre-market on this;

New Research Demonstrates Broad Efficacy of Azixa(TM) (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
Friday June 15, 12:01 am ET
Study Results Published in Cancer Research


TARRYTOWN, N.Y., June 15 /PRNewswire-FirstCall/ -- EpiCept Corporation (Nasdaq and OMX Stockholm: EPCT) today announced the results of scientific studies that (1) demonstrate that Azixa(TM) (MPC-6827) is effective in treating multiple types of human tumors in animal models, (2) reveal a mechanism by which MPC-6827 exerts its effects, and (3) show that MPC-6827 is not affected by cellular proteins known to be involved in cancer drug resistance. The study results appear in the June 15, 2007 edition of Cancer Research, a journal published by the American Association of Cancer Research (AACR).


More;

http://biz.yahoo.com/prnews/070615/nyf021.html?.v=95